Mindfulness machine: new device may ease anxiety without pills

NCT ID NCT07628153

Completed Symptom relief Sponsor: I.M. Sechenov First Moscow State Medical University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a device called Reacor that uses biofeedback to teach mindfulness by showing your heart rate and brain waves in real time. 188 adults with anxiety disorders were split into three groups: biofeedback alone, the medication escitalopram alone, or both together. The goal was to see if the device could reduce anxiety and improve mindfulness skills.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Escitalopram
What this could lead to: If it works, this could offer a non-drug option for managing anxiety by training the brain to self-regulate.
What could go wrong: This is a small, completed Phase 4 trial with only 188 participants, so results may not apply to everyone. The biofeedback device is not widely available.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANXIETY DISORDERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anxiety disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANXIETY DISORDERS

Contacts and locations

Locations

Department of Psychotherapy of the A.Ya. Kozhevnikov Clinic of Nervous Diseases at the Sechenov University Clinical Center

Moscow, 119991, Russia

More trials for these conditions

Other studies related to the condition(s) this trial covers.